FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Raymond Scott Turner

Research Profile

Chemicals & Drugs

Disorders

Alzheimer's Disease

Anatomy

Living Beings

Co-author Network

Publications

TOP 3
Sang-Ho Choi; Yasuji Matsuoka; Mark P Mattson; Takako Niikura; Raymond Scott Turner; S Sakura Minami; Saba Aid; Luca Caracciolo; Francesca Bosetti
Cyclooxygenase-1 inhibition reduces amyloid pathology and improves memory deficits in a mouse model of Alzheimer's disease.
You Me Sung; Raymond Scott Turner; Hyejin Yoon; Amanda Marie DiBattista; Mira Jung; Jungsu Kim; Taehee Lee; Emily Isabella Moffat; Yoojin Sohn; Jung Min Song; Hyang-Sook Hoe
Mercaptoacetamide-based class II HDAC inhibitor lowers Aβ levels and improves learning and memory in a mouse model of Alzheimer's disease.
Jill G Farmer; Brent T Harris; Barbara J Crain; Raymond Scott Turner
Coexisting adult polyglucosan body disease with frontotemporal lobar degeneration with transactivation response DNA-binding protein-43 (TDP-43)-positive neuronal inclusions.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Raymond Scott Turner (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Sang-Ho Choi; Yasuji Matsuoka; Mark P Mattson; Takako Niikura; Raymond Scott Turner; S Sakura Minami; Saba Aid; Luca Caracciolo; Francesca Bosetti
Cyclooxygenase-1 inhibition reduces amyloid pathology and improves memory deficits in a mouse model of Alzheimer's disease.
Journal of neurochemistry 2013;124(1):59-68.
2013: You Me Sung; Raymond Scott Turner; Hyejin Yoon; Amanda Marie DiBattista; Mira Jung; Jungsu Kim; Taehee Lee; Emily Isabella Moffat; Yoojin Sohn; Jung Min Song; Hyang-Sook Hoe
Mercaptoacetamide-based class II HDAC inhibitor lowers Aβ levels and improves learning and memory in a mouse model of Alzheimer's disease.
Experimental neurology 2013;239():192-201.
2013: Jill G Farmer; Brent T Harris; Barbara J Crain; Raymond Scott Turner
Coexisting adult polyglucosan body disease with frontotemporal lobar degeneration with transactivation response DNA-binding protein-43 (TDP-43)-positive neuronal inclusions.
Neurocase 2013;19(1):67-75.
2011: Patricia L Kramer; Walter A Kukull; William R Markesbery; John C Morris; David A Bennett; David Clark; Deniz Erten-Lyons; Douglas Galasko; Jeffrey A Kaye; Ronald C Petersen; Juan C Troncoso; Raymond Scott Turner; Kathleen A Welsh-Bohmer; Shawn K Westaway; Randall L Woltjer; Haiyan Xu; Jurg Ott
Alzheimer disease pathology in cognitively healthy elderly: a genome-wide study.
Neurobiology of aging 2011;32(12):2113-22.
2011: Lenard W Babus; Juliet Caviness; Eric Chen; Kathleen E Keenoy; So-Yeon Koo; Elizabeth M Little; S Sakura Minami; Daniel T S Pak; G. William Rebeck; Jung Min Song; Raymond Scott Turner; Hyang-Sook Hoe
Decreased dendritic spine density and abnormal spine morphology in Fyn knockout mice.
Brain research 2011;1415():96-102.
2011: Kyle B Womack; Ramon Diaz-Arrastia; Howard J Aizenstein; Steven E Arnold; Nancy R Barbas; Bradley F Boeve; Christopher M Clark; Charles DeCarli; William J Jagust; James B Leverenz; Elaine Peskind; Raymond Scott Turner; Edward Y Zamrini; Judith L Heidebrink; James R Burke; Steven T DeKosky; Martin R Farlow; Matthew J Gabel; Roger Higdon; Claudia H Kawas; Robert A Koeppe; Anne M Lipton; Norman L Foster
Temporoparietal hypometabolism in frontotemporal lobar degeneration and associated imaging diagnostic errors.
Archives of neurology 2011;68(3):329-37.
2011: Sonya B Dumanis; Hyun-Jung Cha; Jung Min Song; Justin H Trotter; Matthew Spitzer; Ji-Yun Lee; Edwin J Weeber; Raymond Scott Turner; Daniel T S Pak; G. William Rebeck; Hyang-Sook Hoe
ApoE receptor 2 regulates synapse and dendritic spine formation.
PloS one 2011;6(2):e17203.
2010: Matthew J Gabel; Norman L Foster; Judith L Heidebrink; Roger Higdon; Howard J Aizenstein; Steven E Arnold; Nancy R Barbas; Bradley F Boeve; James R Burke; Christopher M Clark; Steven T DeKosky; Martin R Farlow; William J Jagust; Claudia H Kawas; Robert A Koeppe; James B Leverenz; Anne M Lipton; Elaine Peskind; Raymond Scott Turner; Kyle B Womack; Edward Y Zamrini
Validation of consensus panel diagnosis in dementia.
Archives of neurology 2010;67(12):1506-12.
2010: kea joo lee; C E H Moussa; Y Lee; Y Sung; Brian Howell; Raymond Scott Turner; Daniel T S Pak; Hyang-Sook Hoe
Beta amyloid-independent role of amyloid precursor protein in generation and maintenance of dendritic spines.
Neuroscience 2010;169(1):344-56.
2010: S Sakura Minami; Elkhansa Sidahmed; Saba Aid; Mika Shimoji; Takako Niikura; Italo Mocchetti; G William Rebeck; Jay S Prendergast; Chris Dealwis; Ronald Wetzel; Francesca Bosetti; Yasuji Matsuoka; Hyang-Sook Hoe; Raymond Scott Turner
Therapeutic versus neuroinflammatory effects of passive immunization is dependent on Aβ/amyloid burden in a transgenic mouse model of Alzheimer's disease.
Journal of neuroinflammation 2010;7():57.
2010: S Sakura Minami; Antoinette Cordova; John R Cirrito; Joseph A Tesoriero; Lenard W Babus; Gary C Davis; Sivanesan Dakshanamurthy; Raymond Scott Turner; Daniel Ts Pak; G. William Rebeck; Mikell Paige; Hyang-Sook Hoe
ApoE mimetic peptide decreases Abeta production in vitro and in vivo.
Molecular neurodegeneration 2010;5():16.
2010: S Sakura Minami; You Me Sung; Sonya B Dumanis; Seong Hwan Chi; Mark P Burns; Eun-Jung Ann; Toshiharu Suzuki; Raymond Scott Turner; Hee-Sae Park; Daniel T S Pak; G. William Rebeck; Hyang-Sook Hoe
The cytoplasmic adaptor protein X11alpha and extracellular matrix protein Reelin regulate ApoE receptor 2 trafficking and cell movement.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2010;24(1):58-69.
2009: Sonya B Dumanis; Joseph A Tesoriero; Lenard W Babus; Madeline T Nguyen; Justin H Trotter; Mary Jo Ladu; Edwin J Weeber; Raymond Scott Turner; Baoji Xu; G William Rebeck; Hyang-Sook Hoe
ApoE4 decreases spine density and dendritic complexity in cortical neurons in vivo.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2009;29(48):15317-22.
2009: Inderjeet Saluja; Henry L Paulson; Ashwin Gupta; Raymond Scott Turner
X11alpha haploinsufficiency enhances Abeta amyloid deposition in Alzheimer's disease transgenic mice.
Neurobiology of disease 2009;36(1):162-8.
2009: Ricardo Capone; Felipe Garcia Quiroz; Panchika Prangkio; Inderjeet Saluja; Anna M Sauer; Mahealani R Bautista; Raymond Scott Turner; Jerry Yang; Michael Mayer
Amyloid-beta-induced ion flux in artificial lipid bilayers and neuronal cells: resolving a controversy.
Neurotoxicity research 2009;16(1):1-13.
2007: Norman L Foster; Judith L Heidebrink; Christopher M Clark; William J Jagust; Steven E Arnold; Nancy R Barbas; Charles DeCarli; Raymond Scott Turner; Robert A Koeppe; Roger Higdon; Satoshi Minoshima
FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease.
Brain : a journal of neurology 2007;130(Pt 10):2616-35.
2006: Raymond Scott Turner
Alzheimer's disease.
Seminars in neurology 2006;26(5):499-506.
2004: Gwendalyn D King; Kay Cherian; Raymond Scott Turner
X11alpha impairs gamma- but not beta-cleavage of amyloid precursor protein.
Journal of neurochemistry 2004;88(4):971-82.
2004: Gwendalyn D King; Raymond Scott Turner
Adaptor protein interactions: modulators of amyloid precursor protein metabolism and Alzheimer's disease risk?
Experimental neurology 2004;185(2):208-19.
2004: Roger Higdon; Norman L Foster; Robert A Koeppe; Charles DeCarli; William J Jagust; Christopher M Clark; Nancy R Barbas; Steven E Arnold; Raymond Scott Turner; Judith L Heidebrink; Satoshi Minoshima
A comparison of classification methods for differentiating fronto-temporal dementia from Alzheimer's disease using FDG-PET imaging.
Statistics in medicine 2004;23(2):315-26.
2003: Raymond Scott Turner
Biomarkers of Alzheimer's disease and mild cognitive impairment: are we there yet?
Experimental neurology 2003;183(1):7-10.
2003: Gwendalyn D King; Ruth G Perez; Michelle L Steinhilb; James R Gaut; Raymond Scott Turner
X11alpha modulates secretory and endocytic trafficking and metabolism of amyloid precursor protein: mutational analysis of the YENPTY sequence.
Neuroscience 2003;120(1):143-54.
2002: Kevin A Corcoran; Ye Lu; Raymond Scott Turner; Stephen Maren
Overexpression of hAPPswe impairs rewarded alternation and contextual fear conditioning in a transgenic mouse model of Alzheimer's disease.
Learning & memory (Cold Spring Harbor, N.Y.) 2002;9(5):243-52.
2002: Peter Hedera; Raymond Scott Turner
Inherited dementias.
Neurologic clinics 2002;20(3):779-808, vii.
2002: Chi S Ho; Vlad Marinescu; Michelle L Steinhilb; James R Gaut; Raymond Scott Turner; Edward L Stuenkel
Synergistic effects of Munc18a and X11 proteins on amyloid precursor protein metabolism.
The Journal of biological chemistry 2002;277(30):27021-8.
2002: M Hong; Gaurang V Shah; Kenneth M Adams; Raymond Scott Turner; Norman L Foster
Spontaneous intracranial hypotension causing reversible frontotemporal dementia.
Neurology 2002;58(8):1285-7.
2002: Michelle L Steinhilb; Raymond Scott Turner; James R Gaut
ELISA analysis of beta-secretase cleavage of the Swedish amyloid precursor protein in the secretory and endocytic pathways.
Journal of neurochemistry 2002;80(6):1019-28.
2002: Jen-Tzer Gau; Michelle L Steinhilb; Tzu-Cheg Kao; Constance J D'Amato; James R Gaut; Kirk A Frey; Raymond Scott Turner
Stable beta-secretase activity and presynaptic cholinergic markers during progressive central nervous system amyloidogenesis in Tg2576 mice.
The American journal of pathology 2002;160(2):731-8.
2002: Raymond Scott Turner
Idiopathic rapid eye movement sleep behavior disorder is a harbinger of dementia with Lewy bodies.
Journal of geriatric psychiatry and neurology 2002;15(4):195-9.
2001: Raymond Scott Turner
Alzheimer's disease in man and transgenic mice: females at higher risk.
The American journal of pathology 2001;158(3):797-801.
2001: Michelle L Steinhilb; Raymond Scott Turner; James R Gaut
The protease inhibitor, MG132, blocks maturation of the amyloid precursor protein Swedish mutant preventing cleavage by beta-Secretase.
The Journal of biological chemistry 2001;276(6):4476-84.
2000: Helena T Mueller; Jean-Paul Borg; Benjamin L Margolis; Raymond Scott Turner
Modulation of amyloid precursor protein metabolism by X11alpha /Mint-1. A deletion analysis of protein-protein interaction domains.
The Journal of biological chemistry 2000;275(50):39302-6.
2000: Raymond Scott Turner; Constance J D'Amato; Ronald D Chervin; Mila Blaivas
The pathology of REM sleep behavior disorder with comorbid Lewy body dementia.
Neurology 2000;55(11):1730-2.
2000: Linas A Bieliauskas; Raymond Scott Turner
What Persian Gulf War syndrome?
The Clinical neuropsychologist 2000;14(3):341-3.
1999: James E Novak; Raymond Scott Turner; Bernard W Agranoff; Stephen K Fisher
Differentiated human NT2-N neurons possess a high intracellular content of myo-inositol.
Journal of neurochemistry 1999;72(4):1431-40.
1999: Jean-Paul Borg; M O Lõpez-Figueroa; M de Taddèo-Borg; Dallas Kroon; Raymond Scott Turner; Stanley J Watson Jr; Benjamin L Margolis
Molecular analysis of the X11-mLin-2/CASK complex in brain.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1999;19(4):1307-16.
1998: Jean-Paul Borg; Samuel W Straight; S M Kaech; M de Taddéo-Borg; Dallas Kroon; David Karnak; Raymond Scott Turner; S K Kim; Benjamin L Margolis
Identification of an evolutionarily conserved heterotrimeric protein complex involved in protein targeting.
The Journal of biological chemistry 1998;273(48):31633-6.
1998: Y k Yang; Raymond Scott Turner; James R Gaut
The chaperone BiP/GRP78 binds to amyloid precursor protein and decreases Abeta40 and Abeta42 secretion.
The Journal of biological chemistry 1998;273(40):25552-5.
1998: Magdalena Sastre; Raymond Scott Turner; Efrat Levy
X11 interaction with beta-amyloid precursor protein modulates its cellular stabilization and reduces amyloid beta-protein secretion.
The Journal of biological chemistry 1998;273(35):22351-7.
1998: Torben R Neelands; Lazar J Greenfield; J Zhang; Raymond Scott Turner; Robert L Macdonald
GABAA receptor pharmacology and subtype mRNA expression in human neuronal NT2-N cells.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1998;18(13):4993-5007.
1998: Jean-Paul Borg; Y k Yang; M De Taddéo-Borg; Benjamin L Margolis; Raymond Scott Turner
The X11alpha protein slows cellular amyloid precursor protein processing and reduces Abeta40 and Abeta42 secretion.
The Journal of biological chemistry 1998;273(24):14761-6.
1997: Raymond Scott Turner; Ronald D Chervin; Kirk A Frey; Satoshi Minoshima; David E Kuhl
Probable diffuse Lewy body disease presenting as REM sleep behavior disorder.
Neurology 1997;49(2):523-7.
1996: D G Cook; Raymond Scott Turner; Dennis L Kolson; Virginia M-Y Lee; Robert W Doms
Vaccinia virus serves as an efficient vector for expressing heterologous proteins in human NTera 2 neurons.
The Journal of comparative neurology 1996;374(4):481-92.
1996: Raymond Scott Turner; N Suzuki; A S Chyung; Steven G Younkin; Virginia M-Y Lee
Amyloids beta40 and beta42 are generated intracellularly in cultured human neurons and their secretion increases with maturation.
The Journal of biological chemistry 1996;271(15):8966-70.
1996: Raymond Scott Turner; L C Kenyon; John Q Trojanowski; Nicholas K Gonatas; Murray Grossman
Clinical, neuroimaging, and pathologic features of progressive nonfluent aphasia.
Annals of neurology 1996;39(2):166-73.
1993: A M Wertkin; Raymond Scott Turner; S J Pleasure; todd golde; Steven G Younkin; John Q Trojanowski; Virginia M-Y Lee
Human neurons derived from a teratocarcinoma cell line express solely the 695-amino acid amyloid precursor protein and produce intracellular beta-amyloid or A4 peptides.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(20):9513-7.
1986: H D Su; B E Kemp; Raymond Scott Turner; J F Kuo
Synthetic myelin basic protein peptide analogs are specific inhibitors of phospholipid/calcium-dependent protein kinase (protein kinase C).
Biochemical and biophysical research communications 1986;134(1):78-84.
1986: J F Kuo; M Shoji; P R Girard; G J Mazzei; Raymond Scott Turner; H D Su
Phospholipid/calcium-dependent protein kinase (protein kinase C) system: a major site of bioregulation.
Advances in enzyme regulation 1986;25():387-400.
1985: Raymond Scott Turner; B E Kemp; H D Su; J F Kuo
Substrate specificity of phospholipid/Ca2+-dependent protein kinase as probed with synthetic peptide fragments of the bovine myelin basic protein.
The Journal of biological chemistry 1985;260(21):11503-7.
1984: Raymond Scott Turner; C H Chou; G J Mazzei; P Dembure; J F Kuo
Phospholipid-sensitive Ca2+ -dependent protein kinase preferentially phosphorylates serine-115 of bovine myelin basic protein.
Journal of neurochemistry 1984;43(5):1257-64.
1984: Raymond Scott Turner; R L Raynor; G J Mazzei; P R Girard; J F Kuo
Developmental studies of phospholipid-sensitive Ca2+-dependent protein kinase and its substrates and of phosphoprotein phosphatases in rat brain.
Proceedings of the National Academy of Sciences of the United States of America 1984;81(10):3143-7.
1984: J F Kuo; R C Schatzman; Raymond Scott Turner; G J Mazzei
Phospholipid-sensitive Ca2+-dependent protein kinase: a major protein phosphorylation system.
Molecular and cellular endocrinology 1984;35(2-3):65-73.
1984: D F Qi; Raymond Scott Turner; J F Kuo
S-100 and other acidic proteins promote Ca2+-independent phosphorylation of protamine catalyzed by a new protein kinase from brain.
Journal of neurochemistry 1984;42(2):458-65.
1984: G J Mazzei; R C Schatzman; Raymond Scott Turner; W R Vogler; J F Kuo
Phospholipid-sensitive Ca2+-dependent protein kinase inhibition by R-24571, a calmodulin antagonist.
Biochemical pharmacology 1984;33(1):125-30.
1983: D F Qi; R C Schatzman; G J Mazzei; Raymond Scott Turner; R L Raynor; S Liao; J F Kuo
Polyamines inhibit phospholipid-sensitive and calmodulin-sensitive Ca2+-dependent protein kinases.
The Biochemical journal 1983;213(2):281-8.
1983: G J Mazzei; D F Qi; R C Schatzman; R L Raynor; Raymond Scott Turner; J F Kuo
Comparative abilities of lanthanide ions La3+ and Tb3+ to substitute for Ca2+ in regulating phospholipid-sensitive Ca2+-dependent protein kinase and myosin light chain kinase.
Life sciences 1983;33(2):119-29.
1983: J F Kuo; R L Raynor; G J Mazzei; R C Schatzman; Raymond Scott Turner; W R Kem
Cobra polypeptide cytotoxin I and marine worm polypeptide cytotoxin A-IV are potent and selective inhibitors of phospholipid-sensitive Ca2+-dependent protein kinase.
FEBS letters 1983;153(1):183-6.
1982: Raymond Scott Turner; C H Chou; R F Kibler; J F Kuo
Basic protein in brain myelin is phosphorylated by endogenous phospholipid-sensitive Ca2+-dependent protein kinase.
Journal of neurochemistry 1982;39(5):1397-404.
1982: B C Wise; D B Glass; C H Chou; R L Raynor; N Katoh; R C Schatzman; Raymond Scott Turner; R F Kibler; J F Kuo
Phospholipid-sensitive Ca2+-dependent protein kinase from heart. II. Substrate specificity and inhibition by various agents.
The Journal of biological chemistry 1982;257(14):8489-95.
1982: N Katoh; R L Raynor; B C Wise; R C Schatzman; Raymond Scott Turner; David M Helfman; J N Fain; J F Kuo
Inhibition by melittin of phospholipid-sensitive and calmodulin-sensitive Ca2+-dependent protein kinases.
The Biochemical journal 1982;202(1):217-24.
1981: D A Hosford; H J Haigler; Raymond Scott Turner
Methionine-enkephalin and morphine: amount ejected microiontophoretically.
Journal of neuroscience methods 1981;4(2):135-9.